10-K · July 24, 2026
Fiscal 2026 sales increased 2% to $6.612 billion, supported by North American contract wins and a 53rd week, but price/mix declined 6% and diluted EPS fell to $2.08 from $2.50. The strategic inflection is improved…
Earnings analysis · 10-Q
Filed October 6, 2026 · Our reading of the company's report
The latest report
Lamb Weston delivered a modest revenue beat at $1.670 billion and an adjusted diluted EPS beat at $0.75, although reported diluted EPS was only $0.21 and declined 54% year over year. North America growth helped offset…
Lamb Weston delivered a modest revenue beat at $1.670 billion and an adjusted diluted EPS beat at $0.75, although reported diluted EPS was only $0.21 and declined 54% year over year. North America growth helped offset continued International weakness, while management raised fiscal 2027 adjusted EPS and EBITDA outlooks and moved its sales outlook to low-single-digit growth. The filing maintained capital expenditure and operating cash flow targets of $380-$410 million and $750-$800 million, respectively, but reported profitability and international performance remain important risks.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Revenue was $1.670 billion, approximately $15 million above the $1.655 billion consensus estimate, indicating a modest sales beat.
Adjusted diluted EPS was $0.75 versus the $0.59 estimate, while reported diluted EPS was $0.21. Management indicated North America growth helped offset continued International weakness.
Fiscal 2027 adjusted EPS guidance was raised to $3.05-$3.35, and adjusted EBITDA guidance increased to $1.125-$1.215 billion from $1.10-$1.20 billion.
Management increased the fiscal 2027 net sales outlook from 0.0%-1.0% growth to low-single-digit growth, while maintaining capital expenditure targets of $380-$410 million.
The company maintained its fiscal 2027 operating cash flow target of $750-$800 million, supporting continued focus on cash generation and cost savings.
As of August 30, 2026, approximately $245 million remained available under the $750 million share-repurchase authorization.
Reported diluted EPS was $0.21, down 54% year over year, despite adjusted diluted EPS of $0.75. The gap indicates material restructuring, legal, or other non-operating charges affecting reported profitability.
International profitability remained weak, with North America growth needed to offset the weakness. The filing also states that the company operates globally and is exposed to currency, commodity-price, and interest-rate volatility.
The company stated there were no material changes to its risk factors, but its market-risk disclosure covers the thirteen weeks ended August 30, 2026, and identifies currency, commodity-price, and interest-rate risks as ongoing exposures.
Fiscal 2027 adjusted EPS outlook was raised to $3.05-$3.35. Management also raised adjusted EBITDA outlook to $1.125-$1.215 billion from $1.10-$1.20 billion and increased the net sales outlook from 0.0%-1.0% growth to low-single-digit growth. Capital expenditure and operating cash flow targets were maintained at $380-$410 million and $750-$800 million, respectively.
Fiscal 2026 sales increased 2% to $6.612 billion, supported by North American contract wins and a 53rd week, but price/mix declined 6% and diluted EPS fell to $2.08 from $2.50. The strategic inflection is improved…
Lamb Weston reported third-quarter net sales of $1,564.8 million, up $44.3 million (3%) versus the prior year quarter, driven by North America volume growth. Profitability compressed: gross profit fell to $331.6 million…
Lamb Weston reported first-quarter fiscal 2026 net sales of $1,659.3 million, essentially flat year-over-year (up $5.2 million) with a favorable foreign currency impact of $23.7 million but a 1% decline at constant…
Lamb Weston reported Q3 net sales of $1,520.5 million, up $62.2 million (4%) year-over-year, driven by a 9% volume increase and North America/International contract wins. Adjusted EBITDA improved $20.2 million to $363.8…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.